Competitor Shortages Allow Amphastar To Deliver ‘Strongest Quarter Yet’

Pending Launches Expected To Drive Future Growth

Gold medal bearing the number one, winner's medal
Amphastar secured GAAP net income of $33.9m during Q4 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business